BYAKANGELICIN | CAS No. 19573-01-4

BYAKANGELICIN

Basic Information

View in Editor

CAS Number

19573-01-4

Molecular Formula

C17H18O7

Molecular Weight

334.3 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

Physical State

Powder

SMILES

View in Editor

CC(C)(C(COC1=C2C(=C(C3=C1OC(=O)C=C3)OC)C=CO2)O)O

InChI

InChI=1S/C17H18O7/c1-17(2,20)11(18)8-23-16-14-10(6-7-22-14)13(21-3)9-4-5-12(19)24-15(9)16/h4-7,11,18,20H,8H2,1-3H3

InChIKey

PKRPFNXROFUNDE-UHFFFAOYSA-N

LogP

2.0584000000000007

Topological Polar Surface Area

102.27000000000001 Å²

Hydrogen Bond Donor/Acceptor

2 / 7

Complexity

503

Synonyms & References

English

HMS3339E03
9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxyfuro[3,2-g]chromen-7-one
DTXSID00346879
AC1LDCJL
7H-Furo[3,2-g][1]benzopyran-7-one, 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-
Byakangellicin
HY-N0075
19573-01-4
NS00067881
CHEBI:168880
MS-25039
FT-0775680
NCGC00385892-01!9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxyfuro[3,2-g]chromen-7-one
9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxyuro[3,2-g]chromen-7-one
(Rac)-Byakangelicin
Mukurozidiol
9-(2,3-dihydroxy-3-methyl-butoxy)-4-methoxy-furo[3,2-g]chromen-7-one
CS-0007117
Byak-angelicin
7H-Furo[3,2-g][1]benzopyran-7-one,9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy
yakangelicin
7H-Furo[3,2-g][1]benzopyran-7-one,9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-
BYAKANGELICIN
byakangellicin
9-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one
Byakangelicin 9-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one

MDL Number

MFCD00468051

FAQ

What regulatory guidelines apply to BYAKANGELICIN (CAS: 19573-01-4)?

BYAKANGELICIN (CAS: 19573-01-4) falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and is regulated under REACH in the European Union. In the United States, it is subject to FDA and EPA regulations for use in pharmaceuticals and cosmetics. Manufacturers and importers are required to register the compound and ensure compliance with relevant regulations for handling, storage, and disposal.

Are there alternatives to BYAKANGELICIN (CAS: 19573-01-4) in synthesis?

There are various alternatives to BYAKANGELICIN (CAS: 19573-01-4) in synthesis, such as isomers like 6,7-dihydro-5H-benzimidazol-2-one and analogs like 6,7-dihydro-5H-benzimidazol-2-one. Common alternative reagents include other biologically active compounds like taxol, paclitaxel, and epigallocatechin gallate (EGCG), which can be used as substitutes depending on the specific application and desired properties.

What is the market or research trend for BYAKANGELICIN (CAS: 19573-01-4)?

The market for BYAKANGELICIN (CAS: 19573-01-4) is seeing increased interest due to its potential anti-inflammatory and anticancer properties. Research trends are focusing on its application in drug discovery and development for various diseases. Market demand is growing, driven by ongoing clinical trials and its potential as a natural product extract for therapeutic use. Price trends are influenced by supply chain dynamics and regulatory changes.

How should waste containing BYAKANGELICIN (CAS: 19573-01-4) be handled?

Waste containing BYAKANGELICIN (CAS: 19573-01-4) should be collected in dedicated containers and stored in a well-ventilated area. Incineration is a common method for disposal, but professional waste disposal services should be used for safe handling. Environmental protection precautions include ensuring no residue is released into the environment and following local regulations for hazardous waste management. Training is essential for personnel involved in waste handling and disposal.